ondansetron has been researched along with Stillbirth in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Stillbirth: The event that a FETUS is born dead or stillborn.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the association between ondansetron exposure during pregnancy and the risks of spontaneous abortion, stillbirth, and major congenital malformations." | 9.12 | Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. ( Dahl, M; Dormuth, CR; Filion, KB; Fisher, A; Lu, X; Ma, Z; Moriello, C; Paterson, JM; Platt, RW; Raymond, CB; Reynier, P; Suissa, S; Winquist, B; Wu, F; Zhang, J, 2021) |
| "Ondansetron is frequently used to treat nausea and vomiting during pregnancy, but the safety of this drug for the fetus has not been well studied." | 7.79 | Ondansetron in pregnancy and risk of adverse fetal outcomes. ( Hviid, A; Pasternak, B; Svanström, H, 2013) |
| "To study the association between ondansetron exposure during pregnancy and the risks of spontaneous abortion, stillbirth, and major congenital malformations." | 5.12 | Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. ( Dahl, M; Dormuth, CR; Filion, KB; Fisher, A; Lu, X; Ma, Z; Moriello, C; Paterson, JM; Platt, RW; Raymond, CB; Reynier, P; Suissa, S; Winquist, B; Wu, F; Zhang, J, 2021) |
| "Ondansetron is frequently used to treat nausea and vomiting during pregnancy, but the safety of this drug for the fetus has not been well studied." | 3.79 | Ondansetron in pregnancy and risk of adverse fetal outcomes. ( Hviid, A; Pasternak, B; Svanström, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dormuth, CR | 1 |
| Winquist, B | 1 |
| Fisher, A | 1 |
| Wu, F | 1 |
| Reynier, P | 1 |
| Suissa, S | 1 |
| Dahl, M | 1 |
| Ma, Z | 1 |
| Lu, X | 1 |
| Zhang, J | 1 |
| Raymond, CB | 1 |
| Filion, KB | 1 |
| Platt, RW | 1 |
| Moriello, C | 1 |
| Paterson, JM | 1 |
| Pasternak, B | 1 |
| Svanström, H | 1 |
| Hviid, A | 1 |
1 review available for ondansetron and Stillbirth
| Article | Year |
|---|---|
Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
Topics: Abortion, Spontaneous; Adult; Antiemetics; Canada; Cohort Studies; Congenital Abnormalities; Databas | 2021 |
1 other study available for ondansetron and Stillbirth
| Article | Year |
|---|---|
Ondansetron in pregnancy and risk of adverse fetal outcomes.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antiemetics; Female; Fetus; Humans; Infan | 2013 |